A series of methylases are involved in the development of metabolic diseases; among them, FTO was found to play a pivotal role in promoting disease, YTHDC2 was believed to suppress disease development, while the role of METTL3 and METTL14 in metabolic disease still needs to be further investigated. Here, METTL3 is linked to metabolic disease.